Lazarus Hospitals Profile
Key Indicators
- Authorised Capital ₹ 19.20 Cr
as on 03-01-2025
- Paid Up Capital ₹ 19.20 Cr
as on 03-01-2025
- Company Age 24 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 32.48 Cr
as on 03-01-2025
- Satisfied Charges ₹ 4.85 Cr
as on 03-01-2025
- Revenue 298.55%
(FY 2021)
- Profit 30.37%
(FY 2021)
- Ebitda -766.20%
(FY 2021)
- Net Worth -1.18%
(FY 2021)
- Total Assets -32.88%
(FY 2021)
About Lazarus Hospitals
The Corporate was formerly known as Lazarus Hospitals Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 19.20 Cr and a paid-up capital of Rs 19.20 Cr.
The company currently has active open charges totaling ₹32.48 Cr. The company has closed loans amounting to ₹4.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Varma Vegesna and Chamundeswari Marra serve as directors at the Company.
- CIN/LLPIN
U85110AP2000PTC035186
- Company No.
035186
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Lazarus Hospitals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Varma Vegesna | Managing Director | 28-Aug-2000 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chamundeswari Marra | Additional Director | 01-Mar-2019 | Current |
Financial Performance of Lazarus Hospitals.
Lazarus Hospitals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 298.55% increase. The company also saw a substantial improvement in profitability, with a 30.37% increase in profit. The company's net worth dipped by a decrease of 1.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Lazarus Hospitals?
In 2022, Lazarus Hospitals had a promoter holding of 29.93% and a public holding of 70.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Pridhvi Asset Reconstruction And Securitisation Company Limited Creation Date: 10 Dec 2009 | ₹32.48 Cr | Open |
Bank Of Baroda Creation Date: 29 Jun 2002 | ₹4.85 Cr | Satisfied |
How Many Employees Work at Lazarus Hospitals?
Unlock and access historical data on people associated with Lazarus Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lazarus Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lazarus Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.